[1]
|
A. L. Bisno, “Group A Streptococcal Infections and Acute Rheumatic Fever,” New England Journal of Medicine, Vol. 325, No. 11, 1991, pp. 783-793.
doi:10.1056/NEJM199109123251106
|
[2]
|
S. Padmavati, “Rheumatic Fever and Rheumatic Heart Disease in India at the Turn of the Century,” Indian Heart Journal, Vol. 53, 2001, pp. 35-37.
|
[3]
|
A. Shet and E. Kaplan, “Addressing the Burden of Group A Streptococcal Disease in India,” Indian Journal of Paediatrics, Vol. 71, No. 1, 2004, pp. 41-48.
doi:10.1007/BF02725655
|
[4]
|
J. H. Robinson and M. A. Kehoe, “Group A Streptococcal M Proteins: Virulence Factors and Protective Antigens,” Immunology Today, Vol. 13, No. 9, 1992, pp. 362-367.
doi:10.1016/0167-5699(92)90173-5
|
[5]
|
V. A. Fischetti, “Streptococcal M Protein,” Scientific American, Vol. 264, No. 6, 1991, pp.58-65.
doi:10.1038/scientificamerican0691-58
|
[6]
|
W. A. Hayman, E. R. Brandt, W. A. Relf, J. Cooper, A. Saul and M. F. Good, “Mapping the Minimal Murine T cell and B Cell Epitopes within a Peptide Vaccine Candidate from the Conserved Region of the M Protein of Group A Streptococcus,” International Immunology, Vol. 9, No. 11, 1997, pp. 1723-1733.
doi:10.1093/intimm/9.11.1723
|
[7]
|
S. Pruksakorn, A. Galbraith, R. A. Hougusten and M. F. Good, “Conserved T and B Cell Epitopes on the M Protein of Group A Streptococci. Induction of Bactericidal Antibodies”, The Journal of Immunology, Vol. 149, 1992, pp. 2729-2735.
|
[8]
|
M. R. Batzloff, W. A. Hayman,M. R. Davies, M. Zeng, S.Pruksakorn, E. R. Brandt, M. F. Good, “Protection against Group A Streptococcus by Immunization with J8-Diphtheria Toxoid: Contribution of J8- and Diphtheria Toxoid-Specific Antibodies to Protection,” The Journal of Infectious Diseases, Vol. 187, No. 10, 2003, pp. 1598- 1608. doi:10.1086/374800
|
[9]
|
H. Vohra, N. Dey, S. Gupta, A. K. Sharma, R. Kumar, D. J. McMillan and M. F. Good, “M Protein Conserved Region Antibodies Opsonise Multiple Strains of Streptococcus Pyogenes with Sequence Variations in C-Repeats,” Research in Microbiology, Vol. 156, No. 4, 2005, pp. 575-582.
doi:10.1016/j.resmic.2004.12.009
|
[10]
|
M. M. Georgousakis, A. Hofmann, M. R. Batzloff, D. J. McMillan and K. S. Sriprakash, “Structural Optimisation of a Conformational Epitope Improves Antigenicity When Expressed as a Recombinant Fusion Protein,” Vaccine, Vol. 27, No. 48, 2009, pp. 6799-6806.
doi:10.1016/j.vaccine.2009.08.049
|
[11]
|
T. A. Penfound, E. Y. Chiang, E. A. Ahmed and J. B. Dale, “Protective Efficacy of Group A Streptococcal Vaccines Containing Type-Specific and Conserved M Protein Epitopes,” Vaccine, Vol. 28, No. 31, 2010, pp. 5017-5022. doi:10.1016/j.vaccine.2010.05.018
|
[12]
|
B. Beall, R. Facklam and T. Thompson, “Sequencing Emm-Specific PCR Products for Routine and Accurate Typing of Group A Streptococci,” Journal of Clinical Microbiology, Vol. 34, 1996, pp. 953-958.
|
[13]
|
E. R. Brandit, K. S. Sriprakash, R. I. Hobb, W. A. Hayman, W. Zeng, M. R. Batzloff, D. C. Jackson and M. F. Good, “New Multi-Determinant Strategy for a Group A Streptococcal Vaccine Designed for the Australian Aboriginal Population,” Nature Medicine, Vol. 6, No. 4, 2000, pp. 455-459.
|
[14]
|
M. G. Caparon, R. T. Geist, J. Perez-Casal and J. R. Scott, “Environmental Regulation of Virulence in Group A Streptococci: Transcription of the Gene Encoding M Protein Is Stimulated by Carbon Dioxide,” Journal of Bacteriology, Vol. 174, 1992, pp. 5693-5701.
|
[15]
|
H. S. Courtney, O. I. Penfound, T. V. Nizet, M. A. Pence, B. Kreikemeyer, A. Podbielski, D. L. Hasty and J. B. Dale, “Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus Pyogenes,” PLoS One, Vol. 4, No. 1, 2009, p. e4166.
doi:10.1371/journal.pone.0004166
|
[16]
|
M. R. Batzloff, H. Yan, M. R. Davies, J. Hartas, G. H. Lowell, G. White, D. S. Burt, T. Leanderson and M. F. Good, “Toward the Development of an Antidisease, Transmission-Blocking Intranasal Vaccine for Group A Streptococcus,” The Journal of Infectious Diseases, Vol. 192, No. 8, 2005, pp. 1450-1455. doi:10.1086/466528
|
[17]
|
G. Stollerman, F. Kantor and B. Gordon, “Accessory Plasma Factors Involved in the Bactericidal Test for Type-Specific Antibody to Group A Streptococci. I. Atypical Behavior of Some Human and Animal Bloods,” Journal of Experimental Medicine, Vol. 108, 1958, pp. 475-491. doi:10.1084/jem.108.4.475
|
[18]
|
A. C. Steer, G. Magor, A. W. J. Jenney, J. Kado, M. F. Good, D. J. McMillan, M. Batzloff and J. R. Carapetis “Emm and C-Repeat Region Molecular Typing of Beta- Hemolytic Streptococci in a Tropical Country: Implications for Vaccine Development,” Journal of Clinical, Microbiology, Vol. 47, No. 8, 2009, pp. 2502-2509.
doi:10.1128/JCM.00312-09
|
[19]
|
N. Yoonim, C. Olive, C. Pruksachatkunakorn and S. Pruksakorn, “Bactericidal Activity of M Protein Conserved Region Antibodies against Group A Streptococcal Isolates from the Northern Thai Population,” BMC Microbiology, Vol. 6, 2006, p. 71.
|
[20]
|
J. C. Levin and M. R. Wessels, “Identification of csrR/ csrS, a Genetic Locus That Regulates Hylarunic Acid Capsule Synthesis in Group A Streptococcus,” Molecular Microbiology, Vol. 30, No. 1, 1998, pp. 209-219.
|
[21]
|
P. R. Smeesters, D. J. McMillan and K. S. Sriprakash, “The Streptococcal M Protein: A Highly Versatile Molecule,” Trends in Microbiology, Vol. 18, No. 6, 2010, pp. 275-282. doi:10.1016/j.tim.2010.02.007
|
[22]
|
W. J. Simpson and P. P. Cleary, “Expression of M Type 12 Protein by a Group A Streptococcus Exhibits Phaselike Variation: Evidence for Coregulation of Colony Opacity Determinants and M Protein,” Infection and Immunity, Vol. 55, No. 10, 1987, pp. 2448-2455.
|
[23]
|
S. P. O’Connor and P. P. Cleary, “In Vivo Streptococcus Pyogenes C5a Peptidase Activity: Analysis Using Trans- poson- and Nitrosoguanidine-Induced Mutants,” The Journal of Infectious Diseases, Vol. 156, No. 3, 1987, pp. 495-504. doi:10.1093/infdis/156.3.495
|
[24]
|
W. A. Relf, J. Cooper, E. R. Brandt, W. A. Hayman, R. F. Anders, S. Pruksakorn, B. Currie, A. Saul and M. F. Good, “Mapping a Conserved Conformational Epitope from the M Protein of Group A Streptococci,” Peptide Research, Vol. 9, 1996, pp. 12-20.
|